Home Online Features OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment
OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment
Hand-out
Press Releases
OrthoPreserve, Inc.  
January 29, 2025

OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment

RICHMOND, Va. and ATLANTA, Jan. 29, 2025 /PRNewswire/ -- OrthoPreserve, a company developing orthopedic implant solutions, announced today it has been granted both a Breakthrough Device Designation and Total Product

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social